Ingro Finanz Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Investments
  • 3

  • Exits
  • 2

Exits

Ingro Finanz General Information

Company Description

Ingro Finanz is a venture capital firm based in Nidwalden, Switzerland.

Business Details

Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Corporate Office
  • Sonnhaldenstrasse 20
  • Hergiswil North West
  • 6052 Nidwalden
  • Switzerland

Ingro Finanz Investments (3)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Spexis 12-Apr-2017 PE Growth/Expansion Drug Discovery Generating Revenue
Spexis 17-Jun-2010 Drug Discovery Generating Revenue
Ganymed Pharmaceuticals 18-Apr-2007 Drug Discovery Generating Revenue
To view Ingro Finanz’s complete investments history, request access »

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ingro Finanz Exits (2)

Company Name Exit Date Exit Type Exit Size
Spexis 15-May-2018 IPO
Ganymed Pharmaceuticals 21-Aug-2008
To view Ingro Finanz’s complete exits history, request access »

Ingro Finanz Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Ingro Finanz FAQs

  • What is Ingro Finanz?

    Ingro Finanz is a venture capital firm based in Nidwalden, Switzerland.

  • Where is Ingro Finanz headquartered?

    Ingro Finanz is headquartered in Nidwalden, Switzerland.

  • How many investments has Ingro Finanz made?

    Ingro Finanz has made 3 investments.

  • What has Ingro Finanz invested in?

    Ingro Finanz has made numerous investments in companies like Spexis and Ganymed Pharmaceuticals within the Drug Discovery industry.

  • What has Ingro Finanz invested in recently?

    Ingro Finanz's latest investment was on 12-Apr-2017 in Spexis, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process